United States Cervical Cancer Vaccine Market Report 2016

November 2016 | 96 pages | ID: UAD15B43B86EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Cervical Cancer Vaccine

Revenue, means the sales value of Cervical Cancer Vaccine

Revenue, means the salies sales (consumption) of Cervical Cancer Vaccine in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• MSD
• GSK

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Gardasil
• Cervarix
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Cervical Cancer Vaccine in each application, can be divided into

• HPV6
• HPV11
• HPV16
• HPV18

Contents

United States Cervical Cancer Vaccine Market Report 2016

1 CERVICAL CANCER VACCINE OVERVIEW

1.1 Product Overview and Scope of Cervical Cancer Vaccine
1.2 Classification of Cervical Cancer Vaccine
  1.2.1 Gardasil
  1.2.2 Cervarix
  1.2.3 Type III
1.3 Application of Cervical Cancer Vaccine
  1.3.1 HPV6
  1.3.2 HPV11
  1.3.3 HPV16
  1.3.4 HPV18
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Cervical Cancer Vaccine (2011-2021)
  1.4.1 United States Cervical Cancer Vaccine Sales and Growth Rate (2011-2021)
  1.4.2 United States Cervical Cancer Vaccine Revenue and Growth Rate (2011-2021)

2 UNITED STATES CERVICAL CANCER VACCINE COMPETITION BY MANUFACTURERS

2.1 United States Cervical Cancer Vaccine Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Cervical Cancer Vaccine Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Cervical Cancer Vaccine Average Price by Manufactures (2015 and 2016)
2.4 Cervical Cancer Vaccine Market Competitive Situation and Trends
  2.4.1 Cervical Cancer Vaccine Market Concentration Rate
  2.4.2 Cervical Cancer Vaccine Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES CERVICAL CANCER VACCINE SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Cervical Cancer Vaccine Sales and Market Share by Type (2011-2016)
3.2 United States Cervical Cancer Vaccine Revenue and Market Share by Type (2011-2016)
3.3 United States Cervical Cancer Vaccine Price by Type (2011-2016)
3.4 United States Cervical Cancer Vaccine Sales Growth Rate by Type (2011-2016)

4 UNITED STATES CERVICAL CANCER VACCINE SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Cervical Cancer Vaccine Sales and Market Share by Application (2011-2016)
4.2 United States Cervical Cancer Vaccine Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES CERVICAL CANCER VACCINE MANUFACTURERS PROFILES/ANALYSIS

5.1 MSD
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Cervical Cancer Vaccine Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 MSD Cervical Cancer Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 GSK
  5.2.2 Cervical Cancer Vaccine Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 GSK Cervical Cancer Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview

6 CERVICAL CANCER VACCINE MANUFACTURING COST ANALYSIS

6.1 Cervical Cancer Vaccine Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Cervical Cancer Vaccine

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Cervical Cancer Vaccine Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Cervical Cancer Vaccine Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES CERVICAL CANCER VACCINE MARKET FORECAST (2016-2021)

10.1 United States Cervical Cancer Vaccine Sales, Revenue Forecast (2016-2021)
10.2 United States Cervical Cancer Vaccine Sales Forecast by Type (2016-2021)
10.3 United States Cervical Cancer Vaccine Sales Forecast by Application (2016-2021)
10.4 Cervical Cancer Vaccine Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX

Disclosure Section
Research Methodology
Data Source
Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Cervical Cancer Vaccine
Table Classification of Cervical Cancer Vaccine
Figure United States Sales Market Share of Cervical Cancer Vaccine by Type in 2015
Figure Gardasil Picture
Figure Cervarix Picture
Table Application of Cervical Cancer Vaccine
Figure United States Sales Market Share of Cervical Cancer Vaccine by Application in 2015
Figure HPV6 Examples
Figure HPV11 Examples
Figure HPV16 Examples
Figure HPV18 Examples
Figure United States Cervical Cancer Vaccine Sales and Growth Rate (2011-2021)
Figure United States Cervical Cancer Vaccine Revenue and Growth Rate (2011-2021)
Table United States Cervical Cancer Vaccine Sales of Key Manufacturers (2015 and 2016)
Table United States Cervical Cancer Vaccine Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Cervical Cancer Vaccine Sales Share by Manufacturers
Figure 2016 Cervical Cancer Vaccine Sales Share by Manufacturers
Table United States Cervical Cancer Vaccine Revenue by Manufacturers (2015 and 2016)
Table United States Cervical Cancer Vaccine Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Cervical Cancer Vaccine Revenue Share by Manufacturers
Table 2016 United States Cervical Cancer Vaccine Revenue Share by Manufacturers
Table United States Market Cervical Cancer Vaccine Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Cervical Cancer Vaccine Average Price of Key Manufacturers in 2015
Figure Cervical Cancer Vaccine Market Share of Top 3 Manufacturers
Figure Cervical Cancer Vaccine Market Share of Top 5 Manufacturers
Table United States Cervical Cancer Vaccine Sales by Type (2011-2016)
Table United States Cervical Cancer Vaccine Sales Share by Type (2011-2016)
Figure United States Cervical Cancer Vaccine Sales Market Share by Type in 2015
Table United States Cervical Cancer Vaccine Revenue and Market Share by Type (2011-2016)
Table United States Cervical Cancer Vaccine Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Cervical Cancer Vaccine by Type (2011-2016)
Table United States Cervical Cancer Vaccine Price by Type (2011-2016)
Figure United States Cervical Cancer Vaccine Sales Growth Rate by Type (2011-2016)
Table United States Cervical Cancer Vaccine Sales by Application (2011-2016)
Table United States Cervical Cancer Vaccine Sales Market Share by Application (2011-2016)
Figure United States Cervical Cancer Vaccine Sales Market Share by Application in 2015
Table United States Cervical Cancer Vaccine Sales Growth Rate by Application (2011-2016)
Figure United States Cervical Cancer Vaccine Sales Growth Rate by Application (2011-2016)
Table MSD Basic Information List
Table MSD Cervical Cancer Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Figure MSD Cervical Cancer Vaccine Sales Market Share (2011-2016)
Table GSK Basic Information List
Table GSK Cervical Cancer Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table GSK Cervical Cancer Vaccine Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Cervical Cancer Vaccine
Figure Manufacturing Process Analysis of Cervical Cancer Vaccine
Figure Cervical Cancer Vaccine Industrial Chain Analysis
Table Raw Materials Sources of Cervical Cancer Vaccine Major Manufacturers in 2015
Table Major Buyers of Cervical Cancer Vaccine
Table Distributors/Traders List
Figure United States Cervical Cancer Vaccine Production and Growth Rate Forecast (2016-2021)
Figure United States Cervical Cancer Vaccine Revenue and Growth Rate Forecast (2016-2021)
Table United States Cervical Cancer Vaccine Production Forecast by Type (2016-2021)
Table United States Cervical Cancer Vaccine Consumption Forecast by Application (2016-2021)